Key Quantitative Figures

Standalone Financial Results (FY26 vs FY25):

  • Revenue from operations: ₹166.32 lakhs (FY25) vs ₹0.00 lakhs (FY26) - Note: FY26 shows zero revenue from operations
  • Other income: ₹130.18 lakhs (FY26) vs ₹10.03 lakhs (FY25)
  • Total income: ₹130.18 lakhs (FY26) vs ₹176.35 lakhs (FY25)
  • Net profit/(loss): ₹54.20 lakhs profit (FY26) vs ₹(171.87) lakhs loss (FY25)
  • EPS (Basic): ₹1.03 (FY26) vs ₹(4.77) (FY25)
  • Paid-up equity share capital: ₹559.12 lakhs (FY26) vs ₹360.00 lakhs (FY25)
  • Reserves: ₹1,568.23 lakhs (FY26) vs ₹642.85 lakhs (FY25)

Consolidated Financial Results (FY26 vs FY25):

  • Revenue from operations: ₹267.08 lakhs (FY26) vs ₹197.59 lakhs (FY25)
  • Other income: ₹74.37 lakhs (FY26) vs ₹6.92 lakhs (FY25)
  • Total income: ₹341.45 lakhs (FY26) vs ₹204.51 lakhs (FY25)
  • Net loss: ₹(694.49) lakhs (FY26) vs ₹(148.74) lakhs (FY25)
  • EPS (Basic): ₹(13.19) (FY26) vs ₹(4.13) (FY25)
  • Reserves: ₹959.49 lakhs (FY26) vs ₹624.14 lakhs (FY25)

Subsidiary Performance (FY26):

  • Total assets: ₹259.33 lakhs
  • Total revenues: ₹211.27 lakhs (year), ₹28.44 lakhs (quarter)
  • Net loss after tax: ₹(748.69) lakhs (year), ₹(303.19) lakhs (quarter)
  • Total comprehensive income: ₹(747.14) lakhs (year), ₹(302.69) lakhs (quarter)
  • Net cash inflows: ₹25.54 lakhs (year)

Dates of Action

  • Board meeting: May 23, 2026 (12:00 PM to 1:00 PM IST)
  • Financial period: Quarter and year ended March 31, 2026
  • Approval date: May 23, 2026

Parties Involved

  • Subsidiaries: Truhealthy Wellness Private Limited, Relic Pharma Limited
  • Statutory Auditors: D. Kothary & Co. (Firm Registration No. 105335W)
  • Key personnel: Karthik Swaminathan Iyer, Executive Director (DIN: 08216928)
  • Regulatory reference: Regulation 30 of SEBI (LODR) Regulations, 2015

Capital Structure Impact

  • Significant increase in paid-up equity share capital from ₹360.00 lakhs to ₹559.12 lakhs
  • Issue of equity shares at premium raised ₹1,070.30 lakhs during FY26
  • Reserves increased from ₹642.85 lakhs to ₹1,568.23 lakhs on standalone basis

Cash Flow Implications

Standalone Cash Flow (FY26):

  • Operating activities: Net cash outflow of ₹(1,786.09) lakhs
  • Investing activities: Net cash inflow of ₹50.95 lakhs
  • Financing activities: Net cash inflow of ₹1,069.86 lakhs
  • Net decrease in cash: ₹(665.28) lakhs
  • Ending cash balance: ₹38.48 lakhs

Consolidated Cash Flow (FY26):

  • Operating activities: Net cash outflow of ₹(1,681.62) lakhs
  • Net decrease in cash: ₹(639.74) lakhs
  • Ending cash balance: ₹70.05 lakhs

Additional Notes

  • The company reversed deferred tax assets created on carried forward losses during Q4 FY26
  • Previous periods' figures have been regrouped and reclassified for comparison
  • The company is engaged in a single business segment
  • Figures for the last quarter are balancing figures between audited full-year figures and published unaudited year-to-date figures up to nine months